about
Chemokines as Cancer Vaccine Adjuvants.CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitroClinical utilization of chemokines to combat cancer: the double-edged sword.CCR4-expressing T cell tumors can be specifically controlled via delivery of toxins to chemokine receptors.Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma model.The role of CCL5 in the ability of adipose tissue-derived mesenchymal stem cells to support repair of ischemic regionsCXC receptor and chemokine expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation.CCL19 as an adjuvant for intradermal gene gun immunization in a Her2/neu mouse tumor model: improved vaccine efficacy and a role for B cells as APC.CCL21 (SLC) improves tumor protection by a DNA vaccine in a Her2/neu mouse tumor model.Applications of chemokines as adjuvants for vaccine immunotherapy.CCL19 (ELC) improves TH1-polarized immune responses and protective immunity in a murine Her2/neu DNA vaccination model.
P2860
Q33792344-32430879-FB76-4CF0-8B6F-A5A06035ADAEQ35688332-078528BC-4167-4551-B8BF-6D58EFC284F9Q36488894-86CCF7AA-DE3B-4809-AB20-66A45072A6DDQ36488901-8F228D82-19CB-4E53-8EAD-D3E7133C4FAAQ37516937-DF91A9C0-CA21-45E8-BBF1-17EAEB423DAFQ37592479-0E336D51-8A78-4D13-B408-5D62E0685261Q38303390-AF2689AF-432D-40DB-9A60-4E82C5C91028Q39253157-3A2A8A43-B2CD-475D-991C-4D9E5D0386D7Q39458469-E9FC0C0C-1682-4F43-A697-3892DC351FD7Q47288431-07124AB8-E33B-4FBE-A981-73213766C16EQ52890329-4AC24B2F-97A6-48E4-9833-99535BD790A2
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cancer immunotherapy with chemoattractant peptides.
@ast
Cancer immunotherapy with chemoattractant peptides.
@en
type
label
Cancer immunotherapy with chemoattractant peptides.
@ast
Cancer immunotherapy with chemoattractant peptides.
@en
prefLabel
Cancer immunotherapy with chemoattractant peptides.
@ast
Cancer immunotherapy with chemoattractant peptides.
@en
P1476
Cancer immunotherapy with chemoattractant peptides
@en
P2093
Arya Biragyn
P304
P356
10.1016/J.SEMCANCER.2003.10.008
P50
P577
2004-06-01T00:00:00Z